84 related articles for article (PubMed ID: 14975520)
1. Paroxetine for hepatopulmonary syndrome?
Altschuler EL; Kast RE
Med Hypotheses; 2004; 62(3):446-7. PubMed ID: 14975520
[TBL] [Abstract][Full Text] [Related]
2. A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine.
Yilmaz S; Dursum M; Canoruç F; Bayan K; Karabulut A; Akay H
Neth J Med; 2005 Dec; 63(11):448-52. PubMed ID: 16397315
[TBL] [Abstract][Full Text] [Related]
3. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.
Ling Y; Zhang J; Luo B; Song D; Liu L; Tang L; Stockard CR; Grizzle WE; Ku DD; Fallon MB
Hepatology; 2004 Jun; 39(6):1593-602. PubMed ID: 15185300
[TBL] [Abstract][Full Text] [Related]
4. Hepatopulmonary syndrome.
Gaines DI; Fallon MB
Liver Int; 2004 Oct; 24(5):397-401. PubMed ID: 15482333
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
Martínez-Palli G; Taurà P; Balust J; Beltrán J; Zavala E; Garcia-Valdecasas JC
Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine is a novel nitric oxide synthase inhibitor.
Finkel MS; Laghrissi-Thode F; Pollock BG; Rong J
Psychopharmacol Bull; 1996; 32(4):653-8. PubMed ID: 8993087
[TBL] [Abstract][Full Text] [Related]
7. Childhood cirrhosis, hepatopulmonary syndrome and liver transplantation.
Tumgor G; Arikan C; Yuksekkaya HA; Cakir M; Levent E; Yagci RV; Kilic M; Aydogdu S
Pediatr Transplant; 2008 May; 12(3):353-7. PubMed ID: 18435611
[TBL] [Abstract][Full Text] [Related]
8. Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Almeida JA; Riordan SM; Liu J; Galhenage S; Kim R; Bihari D; Wegner EA; Cranney GB; Thomas PS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):341-6. PubMed ID: 17353701
[TBL] [Abstract][Full Text] [Related]
9. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome.
Gómez FP; Barberà JA; Roca J; Burgos F; Gistau C; Rodríguez-Roisin R
Hepatology; 2006 May; 43(5):1084-91. PubMed ID: 16628648
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in patients with hepatopulmonary syndrome undergoing liver transplantation.
Kim HY; Choi MS; Lee SC; Park SW; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Transplant Proc; 2004 Nov; 36(9):2762-3. PubMed ID: 15621142
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment for hepatopulmonary syndrome.
Eshraghian A; Kamyab AA; Yoon SK
Biomed Res Int; 2013; 2013():670139. PubMed ID: 24102057
[TBL] [Abstract][Full Text] [Related]
12. Therapy Insight: hepatopulmonary syndrome and orthotopic liver transplantation.
Pastor CM; Schiffer E
Nat Clin Pract Gastroenterol Hepatol; 2007 Nov; 4(11):614-21. PubMed ID: 17978818
[TBL] [Abstract][Full Text] [Related]
13. Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents.
Añel RM; Sheagren JN
Clin Infect Dis; 2001 May; 32(10):E131-6. PubMed ID: 11317264
[TBL] [Abstract][Full Text] [Related]
14. Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism.
Lau EM; McCaughan G; Torzillo PJ
Liver Transpl; 2010 Jul; 16(7):870-3. PubMed ID: 20583080
[TBL] [Abstract][Full Text] [Related]
15. Hepatopulmonary syndrome in patients with hypoxic hepatitis.
Fuhrmann V; Madl C; Mueller C; Holzinger U; Kitzberger R; Funk GC; Schenk P
Gastroenterology; 2006 Jul; 131(1):69-75. PubMed ID: 16831591
[TBL] [Abstract][Full Text] [Related]
16. Frequency of hepatopulmonary syndrome in cirrhotic patients.
Shafiq M; Khan AA; Alam A; Butt AK; Shafqat F; Malik K; Amin J; Hassan W
J Coll Physicians Surg Pak; 2008 May; 18(5):278-81. PubMed ID: 18541081
[TBL] [Abstract][Full Text] [Related]
17. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience.
Carey EJ; Douglas DD; Balan V; Vargas HE; Byrne TJ; Moss AA; Mulligan DC
Liver Transpl; 2004 Apr; 10(4):529-33. PubMed ID: 15048796
[TBL] [Abstract][Full Text] [Related]
18. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
Mandell MS
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.
Aucejo F; Miller C; Vogt D; Eghtesad B; Nakagawa S; Stoller JK
Liver Transpl; 2006 Aug; 12(8):1278-82. PubMed ID: 16937330
[TBL] [Abstract][Full Text] [Related]
20. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
Krowka MJ
Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
